KINETA, INC. AMENDMENT NO. 5 TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 21st, 2023 • Kineta, Inc./De • Pharmaceutical preparations • Delaware
This Amendment No. 5 to Securities Purchase Agreement (this “Amendment”) is made as of July __, 2023, by and among Kineta, Inc., a Delaware corporation (formerly known as Yumanity Therapeutics, Inc.) (the “Company”), and the undersigned Purchasers (as defined in the PIPE Agreement, which is defined below) constituting a majority in interest of the Purchasers. Capitalized terms used herein but not otherwise defined herein shall have the meanings given to them in the PIPE Agreement.
